Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Initial Public Offering
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:date |
2022-10-20
|
| gptkbp:grossProceeds |
$175 million
|
| https://www.w3.org/2000/01/rdf-schema#label |
Prime Medicine IPO
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:leadUnderwriters |
gptkb:J.P._Morgan
gptkb:Morgan_Stanley gptkb:Jefferies |
| gptkbp:offeredBy |
$17 per share
|
| gptkbp:offers |
10,294,118
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:PRME
|
| gptkbp:subjectOf |
gptkb:Prime_Medicine
|
| gptkbp:bfsParent |
gptkb:ARCH_Venture_Partners
|
| gptkbp:bfsLayer |
6
|